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Campylobacter jejuni gastroenteritis is the most frequent organism associated with acute infectious diarrhea worldwide. (e
clinical presentation involves fever, diarrhea, rigors, and myalgias. Other extraintestinal symptoms that have been described
involve delirium and other neurological complications, and the most well-known is Guillain-Barre´, where there is cross-reactivity
between the gastrointestinal tract and the brain. Despite previously described multiple neurological complications, there is a lack
of clinical data on the association of Campylobacter-related gastroenteritis with acute encephalopathy in immunocompetent
patients. (e type of population, immunocompetent stage, and unfamiliarity with the clinical presentation makes this a
challenging diagnosis for clinicians. We report a case of Campylobacter gastroenteritis associated with acute encephalopathy in an
immunocompetent patient.
1. Introduction
Campylobacter jejuni (C. jejuni) is the most frequent or-
ganism associated with acute bacterial gastroenteritis around
the world [1].(e high incidence of Campylobacter diarrhea,
as well as its duration and possible complications, makes it
highly important from a socioeconomic perspective [2]. It is
estimated to cause 1.3 million human illnesses every year
with 96 million cases in 2010 in the United States [3]. (e
clinical presentation is characterized mainly by abdominal
pain and diarrhea. A prodrome phase characterized by fever,
rigors, myalgias, and occasional delirium has been described
[2]. (e most well-known postinfectious neurological
complications are Guillain-Barre´ syndrome (GBS) and
Miller-Fisher syndrome (MFS) [4]. Furthermore, worldwide
the incidence is 1 to 2 in 100,000 and 1 to 2 in 1,000,000, for
GBS and MFS, respectively [5]. Nearly 30–40% of GBS
patients had C. jejuni infection 2 weeks prior to onset of
neurological symptoms [6]. Other less frequent neurological
complications include Bickerstaff’s brainstem encephalitis,
acute transverse myelitis, and acute disseminated enceph-
alomyelitis (ADEM) [4, 7–9]. We present a case of
Campylobacter gastroenteritis presenting with associated
encephalopathy in an immunocompetent patient.
2. Case
A twenty-five-year-old female with unremarkable past
medical history was brought to the emergency department
due to progressive altered mental status. Per family report,
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the patient was in her usual state of health until one week
before this admission when she started to experience ab-
dominal pain and diarrhea. (e patient’s mother described
episodes of anxiety and unusual behavior-associated con-
fusion specially the day before admission.
On the day of admission, the patient sought medical
attention at an outpatient clinic. While in the office, she
became confused and later she experienced a witnessed
seizure. (e patient received a dose of lorazepam prior to
arrival at the hospital. On arrival to the emergency de-
partment, she was found unresponsive with a Glasgow
Coma Scale of six. She was afebrile and tachycardic with a
heart rate of 115 beats per minute. (e rest of her vital signs
were within normal limits.
Her physical exam was remarkable for generalized de-
creased muscle tone and no clear focal deficits. (e patient
was intubated for airway protection. She was given a loading
dose of levetiracetam and was admitted to the neurosciences
intensive care unit.
Her initial laboratory tests showed respiratory alkalosis
with an elevated white blood cell count at 11.6 th/μl with
76.5% of neutrophils. Her complete metabolic panel showed
hypokalemia. Her urine toxicology, serum alcohol levels,
and urine analysis were unremarkable. C-reactive protein
was 3.3mg/dL, and her lactic acid was 1.2mmol/L. Blood
tests are summarized in Table 1.
A brain computed tomography (CT) without contrast
showed slightly increased low density in the left occipital
white matter compared to the right which increased the
suspicion of posterior reversible encephalopathy syndrome
(PRES), and these images are shown in Figure 1. Herpes
simplex virus (HSV) encephalitis and autoimmune epilepsy
were also considered in the differential diagnosis. (e brain
CT with perfusion was negative for stroke. Chest X-ray
showed atelectatic changes in the right upper lobe. A CT of
the abdomen and pelvis was negative for ovarian teratoma.
(e patient was started on acyclovir for suspected herpetic
encephalitis.
A brain magnetic resonance (MRI) was negative for
findings supporting the diagnosis of PRES. (e electroen-
cephalogram showed no evidence of seizure activity or epi-
leptiform discharges. Lumbar puncture was performed, and
the cerebrospinal fluid (CSF) had a clear appearance. (e
opening pressure was normal. (e CSF glucose was elevated
at 91 units. (e CSF white blood cell count was 3/μL. Further
studies on CSF for ruling out meningitis were done, and they
included Cryptococcus neoformans/gattii, Cytomegalovirus,
Enterovirus CSF, E. coli K1, Hemophilus influenzae, Human
Parechovirus, Listeria monocytogenes, Neisseria meningitidis,
Streptococcus agalactiae, Streptococcus pneumoniae, varicella-
zoster, and herpes simplex virus 1, 2, and 6, which were
negative; details are shown in Table 2.
(e infectious disease team was consulted, and doxy-
cycline was added due to the high prevalence of typhus in the
area. Febrile agglutinins, West Nile virus, and fungal se-
rologies were also negative (Table 1).
CSF studies for autoimmune epilepsy, including
N-methyl-D-aspartate (NMDA) receptor antibodies, gluta-
mic acid decarboxylase (GAD-65) antibodies, and voltage-
gated potassium channel (VGKC) antibodies, were negative
for autoimmune epilepsy, themore detailed studies in Table 2.
Human immunodeficiency virus was negative. Autoimmune
panel was negative for antineutrophil cytoplasmic antibodies
(ANCAs), antinuclear antibody (ANA), and double stranded
DNA (dsDNA) antibodies.
Due to persistent diarrhea during the initial day of
admission, a gastrointestinal infectious panel was ordered
and was positive for C. jejuni (Table 3).
Based on the clinical scenario of a patient with extra-
intestinal complications of Campylobacter infection, it was
decided to start azithromycin 500mg per mouth for at least
10 days. (e patient showed significant improvement after
the first dose and recovered over the next few days prior to
discharge.
3. Discussion
We are describing a case of Campylobacter jejuni gastro-
enteritis associated with acute encephalopathy in an im-
munocompetent adult. (e complex initial presentation
with neurological symptoms makes this clinical scenario a
diagnostic challenge due to the unfamiliarity of clinicians
with this disease.
Campylobacter species belongs to a distinct group of
specialized Gram-negative bacteria designated as rRNA
superfamily VI [10]. (e most important species that can
cause human disease are C. jejuni and C. coli [11]. Cam-
pylobacters invade the intestinal epithelium using flagella,
high molecular weight plasmids, superficial adhesins, and
chemotactic factors [12].
Patients infected with C. jejuni gastroenteritis experience
acute watery or bloody diarrhea, fever, weight loss, and
cramps that last six days on average [11]. Besides the gas-
trointestinal local infection, Campylobacter species also can
cause a range of other clinical manifestations or post-
infectious immune disorders [13].
While infection with C. jejuni can occur in patients of all
ages, this infection is more prevalent in toddlers and young
adults than in other age groups [14]. Despite most of the
neurologic complications associated with Campylobacter
enteritis have been historically linked to the pediatric
population, some of these manifestations have been also
described in adults [9].
Our patient had an unusual presentation of C. jejuni
gastroenteritis associated with acute encephalopathy. Based
on her initial symptoms, she was treated with acyclovir for
the suspicion of HSV encephalitis. Moreover, the combi-
nation of seizures in association with the abnormalities
noted in the mentioned neuroimaging raised the initial
suspicion for PRES and autoimmune epilepsy. (ese diag-
noses were ruled out with a brain MRI and a CSF auto-
immune panel, respectively [15–17].
Other autoimmune systemic diseases including lupus
and vasculitis were ruled out with negative ANCA, ANA,
and dsDNA.We also considered ADEM following aC. jejuni
gastroenteritis in our differential diagnosis. Nonetheless, the
MRI did not show increased T2-signal intensity in the white
matter which is a characteristic neuroimaging finding in
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ADEM [4]. Furthermore, patients suffering ADEM only
improve with high-dose steroids that our patient never
received [4].
Based on Rio Grande Valley demographics with high
prevalence of murine typhus in the area, the patient was
treated empirically with doxycycline until her agglutinins
Table 1: Blood studies.
Blood analysis Result Reference range
Complete blood count
White blood cell 11.6 (4.8–10.9) th/μL
Percent neutrophils 76.5 (49.0–77.6) %
Percent lymphocytes 17.7 (11.8–40.8) %
Percent monocytes 5 (3.70–11.80) %
Percent eosinophils 0.2 (0–4.8) %
Percent basophils 0.3 (0–1.3) %
Percent immature granulocytes 0.3 (0–1) %
Hemoglobin 12.6 (10.8–14.7) gm/dL
Hematocrit 36.8 (32.2–42.9) %
Mean corpuscular volume 87.4 (84–96) fL
Mean corpuscular hemoglobin 29.9 (28.3–32.3) pg
Mean corpuscular hemoglobin concentration 34.2 (29.58–33.75) gm/dL
Platelet count 212 (146–388) th/μL
Red blood cell distribution width CV 12 (12.20–15.80) %
Red blood cell distribution width SD 38.6 (38.93–51.44) fL
Complete metabolic panel
Sodium 136 (132–143) mmol/L
Potassium 3.3 (3.5–5.1) mmol/L
Chloride 105 (98–107) mmol/L
Carbon dioxide 23 (21–31) mmol/L
Creatinine 0.7 (0.6–1.2) mg/dL
BUN 12 (7–25) mg/dL
Calcium 8.8 (8.6–10.3) mg/dL
Glucose 119 (70–113) mg/dL
Ammonia 30 (16–53) umol/L
AST 17 (13–39) IU/L
ALT 15 (7–52) IU/L
Alkaline phosphatase 73 (34–104) IU/L
Albumin 4.1 (3.7–4.9) gm/dL
Total bilirubin 0.3 (0.2–1.2) mg/dL
Coagulation studies
PT 12.9 (10.6–13) second
INR 1.11 (0.90–1.10) INR
PTT 22.8 (24–36.7) second
Others
Sedimentation rate 46 2–30mm/hr
C-reactive protein 3.3 <1mg/dL
Lactic acid 1.2 (0.5–1.99) mmol/L
Alcohol serum <10.00 <10.00mg/dL
Alcohol serum calculation <0.01 <0.01 gm/dL
Serology
ANCA screen∗ Negative Negative
dsDNA 1.5 <10 IU/mL
Symphony ANA screen 0.1 <0.7 ratio
Symphony ANA 0.2 <0.7 ratio
Complement C3 156 (87–200) mg/dL
Complement C4 26 (19–52) mg/dL
Infectious studies
HIV antibodies Nonreactive Nonreactive
Aspergillus flavus antibody Negative Negative
Aspergillus niger antibody Negative Negative
Aspergillus fumigatus antibody Negative Negative
Coccidioides antibody Negative Negative
Histoplasma antibody Negative Negative
Blastomycosis antibody Negative Negative
Febrile agglutinin panel∗ Negative Negative
Respiratory viral panel PCR∗ Negative Negative∗ANCA screen: p-ANCA, c-ANCA, and atypical p-ANCA. ∗Febrile agglutinin panel: P-OX19, POX2, P-OXK, and Brucella. ∗Respiratory viral panel includes
adenovirus, coronavirus, influenza A, influenza B, human metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, Enterovirus, Bordetella
pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.
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Figure 1: CT head without contrast showing increased low density in the left occipital white matter.
Table 2: CSF studies.
Variable Result Reference range
General analysis
CSF appearance Clear Clear
CSF WBC 3 0–5/μL
CSF RBC 0 0/μL
CSF glucose 91 40–70mg/dL
CSF total protein 26 15–45mg/dL
Infectious studies
CSF Cryptococcus neoformans/gattii antigen Not detected Not detected
CSF Cytomegalovirus Not detected Not detected
CSF Enterovirus Not detected Not detected
CSF Escherichia coli K1 Not detected Not detected
CSF Hemophilus influenzae Not detected Not detected
CSF herpes simplex virus 1 Not detected Not detected
CSF herpes simplex virus 2 Not detected Not detected
CSF human herpes virus 6 Not detected Not detected
CSF human Parechovirus Not detected Not detected
CSF Listeria monocytogenes Not detected Not detected
Neisseria meningitidis Not detected Not detected
Streptococcus agalactiae Not detected Not detected
Streptococcus pneumoniae Not detected Not detected
Varicella-zoster virus Not detected Not detected
CSF West Nile IgM <0.90 <0.90
CSF culture No growth No growth
Autoimmune studies
CSF VGKC antibody <20 <20 pmol/L
CSF NMDA receptor antibody Negative Negative
CSF NMDAR1 antibody, CBA Negative Negative
CSF AMPAR1 antibody, CBA Negative Negative
CSF AMPAR2 antibody, CBA Negative Negative
GABABR antibody, CBA Negative Negative
LGI1 antibody, CBA Negative Negative
CASPR2 antibody, CBA Negative Negative
GAD-65 <5 <5 IU/mL
VGKC: voltage-gated potassium channel; NMDA: N-methyl-D-aspartate; AMPAR: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor;
GABA: gamma aminobutyric acid B receptor; LGI1: leucine-rich glioma-inactivated 1; CASPR2: contactin-associated protein 2; GAD: glutamic acid
decarboxylase.
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were negative [18]. In this clinical case, the neurological and
gastrointestinal symptoms rapidly resolved once the patient
was started on azithromycin for Campylobacter gastroen-
teritis. Azithromycin is the antibiotic of choice, has good
coverage for Campylobacter jejuni, shortens the duration of
symptoms, and decreases resistance compared to fluo-
roquinolones [19, 20].
At this present time, the exact pathophysiology of
Campylobacter gastroenteritis associated with encephalop-
athy is unknown, but it is possible that mechanisms in-
volving antibody cross-reactivity may play a role [9]. For
example, it is well known that bidirectional signaling exists
between the gastrointestinal tract and the brain in Guillain-
Barre´ syndrome after a C. jejuni infection, where the outer
membrane structures of Campylobacter containing sialic
acid resemble those seen in the human gangliosides [9].(is
brings the topic of gut-brain axis, which explains that ev-
erything is interconnected: the gut can influence the brain,
the brain can influence the gut, and they both can influence
and be influenced by the immune system [21].
(ere are only a few cases of Campylobacter gastroen-
teritis with encephalopathy in immunocompetent pop-
ulation, and one of them went through a similar analysis
process of differential diagnoses, obtained similar workup as
in our patient based on the neurological symptoms, age of
the patient, immunocompetent status, and severity of
symptoms onset, with clinical improvement after starting
antibiotics [9].
Due to the low prevalence of Campylobacter-associated
encephalopathy in adults, we do not recommend assuming
that mental status changes in a patient presenting with
Campylobacter gastroenteritis are necessarily associated with
the infection. A proper and well-directed workup should be
completed to rule out other more frequent and emergent
neurological diseases such as bacterial meningitis or vascular
disease. We would recommend considering Campylobacter-
associated encephalopathy in the differential diagnosis of
diarrhea associated with mental status changes.
Conflicts of Interest
(e authors declare that they have no conflicts of interest.
References
[1] B. M. Allos, “Campylobacter jejuni Infections: update on
emerging issues and trends,” Clinical Infectious Diseases: An
Official Publication of the Infectious Diseases Society of
America, vol. 32, no. 8, pp. 1201–1206, 2001.
[2] World Health Organization, “Campylobacter World Health
Organization newsroom,” 2018, https://www.who.int/news-
room/fact-sheets/detail/campylobacter.
[3] Centers for Disease Control and Prevention, CDC Yellow Book
2020: Health Information for International Travel, Oxford
University Press, New York, NY, USA, 2017.
[4] S. Marziali, E. Picchi, F. Di Giuliano et al., “Acute dissemi-
nated encephalomyelitis following Campylobacter jejuni
gastroenteritis: case report and review of the literature,” e
Neuroradiology Journal, vol. 30, no. 1, pp. 65–70, 2017.
[5] F. Rocha Cabrero and E. H.Morrison,Miller Fisher Syndrome,
StatPearls Publishing, Treasure Island, FL, USA, 2020, https://
www.ncbi.nlm.nih.gov/books/NBK507717/.
[6] B. M. Allos, “Association between Campylobacter Infection
and Guillain-Barre´ syndrome,” e Journal of Infectious
Diseases, vol. 176, no. s2, pp. S125–S128, 1997.
[7] I. Levy, Y. Weissman, Y. Sivan, J. Ben-Ari, and T. Scheinfeld,
“Acute encephalopathy associated with Campylobacter en-
teritis,” BMJ, vol. 293, no. 6544, p. 424, 1986.
[8] R. A. Van der Kruijk, M. J. Affourtit, H. P. Endtz, and
W. F. M. Arts, “Campylobacter jejuni gastroenteritis and acute
Table 3: Stool studies.
Variable Result Reference range
Gastrointestinal analysis Campylobacter Detected Not detected
Clostridium difficile Not detected Not detected
Plesiomonas shigelloides Not detected Not detected
Salmonella Not detected Not detected
Yersinia enterocolitica Not detected Not detected
Vibrio Not detected Not detected
Vibrio cholerae Not detected Not detected
Enteroaggregative E. coli Not detected Not detected
Enteropathogenic E. coli Not detected Not detected
Enterotoxigenic E. coli Not detected Not detected
Shiga-like toxin-producing E. coli Not detected Not detected
E. coli O157 Not detected Not detected
Shigella/enteroinvasive E. coli Not detected Not detected
Cryptosporidium Not detected Not detected
Cyclospora cayetanensis Not detected Not detected
Entamoeba histolytica Not detected Not detected
Giardia lamblia Not detected Not detected
Adenovirus Not detected Not detected
Astrovirus Not detected Not detected
Norovirus Not detected Not detected
Rotavirus Not detected Not detected
Sapovirus Not detected Not detected
Case Reports in Infectious Diseases 5
encephalopathy,” Journal of Infection, vol. 28, no. 1,
pp. 99-100, 1994.
[9] D. Lepur, V. Peterkovic´, S. B. Kovacˇevic´, K. Visˇkovic´,
N. K. Lepur, and M. Kutlesˇa, “Acute encephalopathy asso-
ciated with Campylobacter jejuni enteritis,” Neurological
Sciences, vol. 33, no. 1, pp. 155–158, 2012.
[10] P. Vandamme, E. Falsen, R. Rossau et al., “Revision of
Campylobacter, Helicobacter, and Wolinella taxonomy:
emendation of generic descriptions and proposal of Arco-
bacter gen. nov,” International Journal of Systematic Bacte-
riology, vol. 41, no. 1, pp. 88–103, 1991.
[11] S. M. Man, “(e clinical importance of emerging Campylo-
bacter species,” Nature Reviews Gastroenterology & Hep-
atology, vol. 8, no. 12, pp. 669–685, 2011.
[12] T. M. Wassenaar and M. J. Blaser, “Pathophysiology of
Campylobacter jejuni infections of humans,” Microbes and
Infection, vol. 1, no. 12, pp. 1023–1033, 1999.
[13] N. O. Kaakoush, N. Castaño-Rodr´ıguez, H. M. Mitchell, and
S. M. Man, “Global epidemiology of Campylobacter infec-
tion,” Clinical Microbiology Reviews, vol. 28, no. 3, pp. 687–
720, 2015.
[14] H. L. Nielsen, T. Ejlertsen, J. Engberg, and H. Nielsen, “High
incidence of Campylobacter concisus in gastroenteritis in
North Jutland, Denmark: a population-based study,” Clinical
Microbiology and Infection, vol. 19, no. 5, pp. 445–450, 2013.
[15] R. Raman, R. Devaramane, G. Mukunda Jagadish, and
S. Chowdaiah, “Various imaging manifestations of posterior
reversible encephalopathy syndrome (PRES) on magnetic
resonance imaging (MRI),” Polish Journal of Radiology,
vol. 82, pp. 64–70, 2017.
[16] A. M. L. Quek, J. W. Britton, A. McKeon et al., “Autoimmune
epilepsy,” Archives of Neurology, vol. 69, no. 5, pp. 582–593,
2012.
[17] F. Graus, M. J. Titulaer, R. Balu et al., “A clinical approach to
diagnosis of autoimmune encephalitis,”eLancet Neurology,
vol. 15, no. 4, pp. 391–404, 2016.
[18] Z. Afzal, S. Kallumadanda, F. Wang, V. Hemmige, and
D. Musher, “Acute febrile illness and complications due to
murine typhus, Texas, USA 1,2,” Emerging Infectious Diseases,
vol. 23, no. 8, pp. 1268–1273, 2017.
[19] A. Ternhag, T. Asikainen, J. Giesecke, and K. Ekdahl, “Ameta-
analysis on the effects of antibiotic treatment on duration of
symptoms caused by infection with Campylobacter species,”
Clinical Infectious Diseases, vol. 44, no. 5, pp. 696–700, 2007.
[20] Y. Yang, K. M. Feye, Z. Shi et al., “A historical review on
antibiotic resistance of foodborne Campylobacter,” Frontiers
in Microbiology, vol. 10, p. 1509, 2019.
[21] A. Vojdani and E. Vojdani, “Reaction of antibodies to
Campylobacter jejuni and cytolethal distending toxin B with
tissues and food antigens,”World Journal of Gastroenterology,
vol. 25, no. 9, pp. 1050–1066, 2019.
6 Case Reports in Infectious Diseases
